We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Johan van Rooijen MD

Johan M van Rooijen MD

Medical Oncologist and Clinical Pharmacologist, Martini Hospital, Groningen, The Netherlands

Johan van Rooijen is currently working as a medical oncologist and clinical pharmacologist at the Martini Hospital Groningen. He completed his residency and fellowship in medical oncology at the University Medical Centre Groningen. Later on he was trained and board certified in clinical pharmacology.  Research activities are focused on the practical use of anti cancer treatments in daily practice, including population based retrospective analysis of the implementation of new anti cancer strategies.


Medical oncologist and clinical pharmacologist, Martini Hospital, Groningen, The Netherlands


University of Groningen, The Netherlands, MD

University of Groningen, The Netherlands, Master of Science in Medicine

University of Groningen, The Netherlands, Master of Science in Pharmacy

Postgraduate Training:

Resident, Isala Clinic Zwolle and University Medical Center Groningen (UMCG)

Fellow, University Medical Center Groningen (UMCG)

Board certifications:


Internal medicine

Medical Oncology

Clinical Pharmacology

Clinical interests:

Medical oncology

Clinical Pharmacology